China · Delayed Price · Currency is CNY Porton Pharma Solutions Statistics
Total Valuation
SHE:300363 has a market cap or net worth of CNY 13.34 billion. The enterprise value is 13.95 billion.
| Market Cap | 13.34B |
| Enterprise Value | 13.95B |
Important Dates
The next estimated earnings date is Friday, October 24, 2025.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300363 has 542.18 million shares outstanding. The number of shares has decreased by -1.75% in one year.
| Current Share Class | 542.18M |
| Shares Outstanding | 542.18M |
| Shares Change (YoY) | -1.75% |
| Shares Change (QoQ) | +52.64% |
| Owned by Insiders (%) | 26.88% |
| Owned by Institutions (%) | 8.94% |
| Float | 313.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 184.50 |
| PS Ratio | 4.07 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 2.81 |
| P/FCF Ratio | 222.20 |
| P/OCF Ratio | 27.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.06, with an EV/FCF ratio of 232.40.
| EV / Earnings | -153.88 |
| EV / Sales | 4.25 |
| EV / EBITDA | 30.06 |
| EV / EBIT | 270.10 |
| EV / FCF | 232.40 |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.88 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 4.26 |
| Debt / FCF | 32.90 |
| Interest Coverage | 0.86 |
Financial Efficiency
Return on equity (ROE) is -2.80% and return on invested capital (ROIC) is 0.43%.
| Return on Equity (ROE) | -2.80% |
| Return on Assets (ROA) | 0.37% |
| Return on Invested Capital (ROIC) | 0.43% |
| Return on Capital Employed (ROCE) | 0.74% |
| Revenue Per Employee | 781,148 |
| Profits Per Employee | -21,585 |
| Employee Count | 4,214 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 3.20 |
Taxes
In the past 12 months, SHE:300363 has paid 49.68 million in taxes.
| Income Tax | 49.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +60.29% in the last 52 weeks. The beta is 0.61, so SHE:300363's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +60.29% |
| 50-Day Moving Average | 24.68 |
| 200-Day Moving Average | 18.78 |
| Relative Strength Index (RSI) | 48.28 |
| Average Volume (20 Days) | 22,035,282 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300363 had revenue of CNY 3.28 billion and -90.66 million in losses. Loss per share was -0.17.
| Revenue | 3.28B |
| Gross Profit | 905.22M |
| Operating Income | 51.65M |
| Pretax Income | -105.35M |
| Net Income | -90.66M |
| EBITDA | 385.64M |
| EBIT | 51.65M |
| Loss Per Share | -0.17 |
Balance Sheet
The company has 1.54 billion in cash and 1.98 billion in debt, giving a net cash position of -431.64 million or -0.80 per share.
| Cash & Cash Equivalents | 1.54B |
| Total Debt | 1.98B |
| Net Cash | -431.64M |
| Net Cash Per Share | -0.80 |
| Equity (Book Value) | 5.47B |
| Book Value Per Share | 9.76 |
| Working Capital | 1.50B |
Cash Flow
In the last 12 months, operating cash flow was 478.06 million and capital expenditures -418.03 million, giving a free cash flow of 60.03 million.
| Operating Cash Flow | 478.06M |
| Capital Expenditures | -418.03M |
| Free Cash Flow | 60.03M |
| FCF Per Share | 0.11 |
Margins
Gross margin is 27.59%, with operating and profit margins of 1.57% and -2.76%.
| Gross Margin | 27.59% |
| Operating Margin | 1.57% |
| Pretax Margin | -3.21% |
| Profit Margin | -2.76% |
| EBITDA Margin | 11.75% |
| EBIT Margin | 1.57% |
| FCF Margin | 1.83% |
Dividends & Yields
SHE:300363 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.75% |
| Shareholder Yield | 1.75% |
| Earnings Yield | -0.68% |
| FCF Yield | 0.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 29, 2015. It was a forward split with a ratio of 1.5.
| Last Split Date | Sep 29, 2015 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300363 has an Altman Z-Score of 2.61 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.61 |
| Piotroski F-Score | 6 |